Market Signal Briefing

H&M shares jumped 9% on Thursday after the fashion retailer delivered stronger-than-expected quarterly earnings, boosted by demand for its autumn collections. The Swedish group, the world's second-largest listed clothing retailer, reported operating profit of 4.91 billion crowns for June–August, up from 3.51 billion a year earlier and well above analyst forecasts of 3.68 billion.

Vanguard Dividend Appreciation ETF remains a strong buy for investors seeking steady, long-term growth and reliable dividend appreciation. VIG offers a best-in-class expense ratio of just 0.05%, reinforcing Vanguard's commitment to low-cost investing and maximizing investor returns. The ETF's diversified portfolio balances high-quality growth and dividend stocks, delivering attractive earnings growth and outperforming the S&P 500 since inception.

The banking giant says it has shown the technology improves its algorithmic bond dealing.

25/09/2025 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. INEOS FINANCE PLC Post-stabilisation Period Announcement NO STABILISATION CARRIED OUT [Further to the pre-stabilisation period announcement dated 23/09/25] BNP Paribas (contact: Stanford Hartman telephone: 0207 595 8222) hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/596/2014)) was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities.

AutoZone (AZO) shows strong revenue growth and resilience despite profit pressures. Read here for an investment analysis of AZO stock.

DoubleLine Income Solutions Fund offers high current income with a 10.69% yield, focusing on high-yield and emerging market debt. DSL may benefit from Federal Reserve rate cuts, but its low duration profile could limit upside from bond repricing. The fund's higher expense ratio and historical underperformance versus peers like PTY warrant caution despite stable distributions.

Upgrade TJX Companies to buy, targeting a 10% 1-year return as fundamentals and growth drivers strengthen. TJX's consistent traffic-led comparable sales growth, especially among younger consumers, de-risks the brand and supports long-term relevance. HomeGoods' transformation into a year-round destination drives recurring traffic and smooths seasonal volatility, enhancing TJX's growth outlook.

LONDON & PARIS--(BUSINESS WIRE)--In a wide-scale licensing arrangement, ENGIE – a global energy player serving 20 million consumer contracts worldwide – has chosen Kaluza's Energy Intelligence Platform to deploy cutting-edge digital technologies aimed at enhancing customer experience and accelerating the shift to smarter, cleaner energy. Kaluza was selected by ENGIE for this multi-year, multi-market agreement following a rigorous evaluation of technology providers. Kaluza's platform combines re.

Highlights: Formation has commenced a fully funded 10,000 metre multi-phase drill program at its flagship N2 Gold Project near Matagami, Quebec, host to a global historic resource of ~870,000 ounces comprised of 18 Mt grading 1.5 g/t Au (~809,000 oz Au) across four zones (A, East, RJ-East, and Central)2,3 and 243 Kt grading 7.82 g/t Au (~61,000 oz Au) across the RJ zone2,4. Phase 1 will target the "A" zone, a shallow, highly continuous, low-variability historic gold deposit with ~522,900 ounces of which only ~35% of strike has been drilled (>3.1 km open), and the "RJ" zone, host to high-grade intercepts from historical drill holes as high as 51 g/t Au over 0.8 metres2, which was expanded by Agnico Eagle Mines in 2008 in the most recent drilling at the Property.

Roche Pharmaceuticals' CEO told investors she was "serious" about the goal of becoming a top 3 obesity player. The drugmaker's CT-388 weight loss injection is entering a phase III trial, marking the latest development in its nascent but fast-growing weight-loss portfolio.

The Invesco S&P 500 Momentum ETF is reiterated as a strong buy for its proven momentum-based strategy and consistent outperformance. SPMO's recent rebalancing increased technology exposure and reduced underperforming consumer defensive holdings, enhancing its sector allocation for current market conditions. SPMO delivered a 35.57% return over the past year, nearly doubling the S&P 500's 18.21%, showcasing its effectiveness in volatile markets.

SPDR® Portfolio S&P 500® High Dividend ETF is less performant than the S&P 500 and has dividends in line with Treasury yields. So why take the risk? Because simply it provides S&P 500 anchored exposure with competitive distributions, so it is a meeting point. Because simply it has a competitive distribution and a price supported by the underlying bullish nature of the S&P 500, even if here it has more value traits.

There is a small gap between Nippon Steel and the U.S. government over the authority of a golden share tied to its acquisition of U.S. Steel, the Japanese steelmaker's president said on Thursday.

This announcement contains inside information for the purposes of the retained UK version of the EU Market Abuse Regulation (EU) 596/2014 ("UK MAR").   Arecor Therapeutics plc (“Arecor” or the “Company”) Co-development Agreement with US Insulin Pump Device Company for AT278 and Sale of Royalty and Technology Access Fees for up to $11 million AT278 (500U/mL) is the only ultra-concentrated and ultra-rapid acting insulin in development designed to enable the next generation of longer-wear and miniaturised automated insulin delivery (AID) systems Arecor and Sequel Med Tech, LLC to commit up to $1.3 million each to fund development work in preparation for pivotal Phase 2 trial for AT278-Insulin Pump programme Strategic intent is to progress to a broader co-development and commercialisation partnership for Phase 2 trial and beyond Non-dilutive funds raised through the monetisation of Arecor's royalty rights related to AT220 and milestone and technology access fees related to AT292 Cash runway extended to 1H 2027 Cambridge, UK, 25 September 2025: Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical company focused on drug development and delivery in diabetes and other cardiometabolic diseases, has signed a co-development agreement with Sequel Med Tech LLC (“Sequel”), a company developing state-of-the-art insulin delivery technologies, to combine AT278 (500U/mL) with Sequel's twiist™ Automated Insulin Delivery (AID) system powered by Tidepool, and a royalty financing agreement with Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) (“Ligand”) which will raise non-dilutive capital of up to $11 million (£8.2 million).

Gold and silver steady as Fed rate cut bets clash with Powell's caution. PCE inflation data set to decide the next move for XAU/USD and XAG/USD.

Vaultz Capital PLC (AQSE:V3TC) has hired BitGo Trust Company to act as custodian for its Bitcoin holdings, the company said Thursday, in a move aimed at strengthening security and governance around its digital asset reserves. Vaultz, listed on London's Aquis Exchange, described the appointment as a key step in its treasury strategy as it builds out its digital asset operations.

India considers French engines for fighter jets amid slow US talks, aiming to boost domestic defence manufacturing capabilities.

The $100 billion partnership between Nvidia and OpenAI, announced Monday, represents – for now – the latest mega-deal reshaping the AI infrastructure landscape. The agreement involves non-voting shares tied to massive chip purchases and enough computing power for more than 5 million U.S. households, deepening the mutual dependence between two of AI's most powerful players.

WisdomTree U.S. High Dividend Fund offers high yields and value exposure, making it a strong supplement to core large-cap value ETFs. DHS provides a 3.26% yield, focuses on mature, cash-generative companies, but has high concentration risk in top holdings. Combining DHS with iShares Russell 1000 Value ETF enhances diversification, risk-adjusted returns, and sector balance for value investors.

BYD has overtaken Tesla in the European Union electric vehicle market for the second month running, shaking up what many assumed was an unchallenged race. In August 2025, BYD sold more than 13,500 vehicles across Europe, a staggering 200% increase year-over-year.

- Total non-dilutive funding of up to USD 159 million upon completion of predefined milestones, including near-term committed funding of USD 6 million

Rambus Inc. continues to deliver robust growth, driven by strong DDR5 memory interface chip sales and industry-leading market share. RMBS's diversified business model, resilience to tariffs, and leadership in DDR5, HBM4, and PCIe 7.0 position it for multi-year expansion. Despite a steep valuation after a 110% rally, RMBS's sustained earnings growth is expected to justify its premium over time.

Uranium Royalty Corp. (NASDAQ:UROY) rose to a three-year high after uranium futures in the US soared to a 10-month high of over $80 per pound this week. The price hike comes after U.S.

Liontown Resources Limited (OTCPK:LINRF) Q4 2025 Earnings Call September 24, 2025 9:30 PM EDT Company Participants Antonino Ottaviano - CEO, MD & Director Graeme Pettit - Interim Chief Financial Officer Ryan Hair - Chief Operating Officer Grant Donald - Chief Commercial Officer Conference Call Participants Glyn Lawcock - Barrenjoey Markets Pty Limited, Research Division Presentation Operator Welcome to the Liontown Resources FY '25 Results call. Following the formal presentation, there will be a Q&A session for investors, analysts and media.

Immuneering Announces Pricing of $175 Million Underwritten Public Offering of Class A Common Stock and Concurrent $25 Million Private Placement of Class A